Kuschel C A, Harding J E
Newborn Services, National Women's Hospital, Private Bag 92 189, Auckland, New Zealand.
Cochrane Database Syst Rev. 2004(1):CD000343. doi: 10.1002/14651858.CD000343.pub2.
For term infants, human milk provides adequate nutrition to facilitate growth, as well as potential beneficial effects on immunity and the maternal-infant emotional state. However, the role of human milk in premature infants is less well defined as it contains insufficient quantities of some nutrients to meet the estimated needs of the infant. Observational studies have suggested that infants fed formula have a higher rate of growth than infants who are breast fed. However, there are potential short term and long term benefits from human milk. Commercially-produced multicomponent fortifiers provide additional nutrients to supplement human milk (in the form of protein, calcium, phosphate, and carbohydrate, as well as vitamins and trace minerals).
The main objective was to determine if addition of multicomponent nutritional supplements to human milk leads to improved growth, bone metabolism and neurodevelopmental outcomes without significant adverse effects in premature infants.
Searches were made of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 3003), MEDLINE (searched August 29, 2003), previous reviews including cross references, abstracts, conferences and symposia proceedings, expert informants, journal handsearching mainly in the English language.
All trials utilising random or quasi-random allocation to supplementation of human milk with multiple nutrients or no supplementation in premature infants within a nursery setting were eligible.
Data were extracted using the standard methods of the Cochrane Collaboration and its Neonatal Review Group, with separate evaluation of trial quality and data extraction by each author and synthesis of data using relative risk and weighted mean difference.
Supplementation of human milk with multicomponent fortifiers is associated with short term increases in weight gain, linear and head growth. There is no effect on serum alkaline phosphatase levels; it is not clear if there is an effect on bone mineral content. Nitrogen retention and blood urea levels appear to be increased. There are insufficient data to evaluate long term neurodevelopmental and growth outcomes, although there appears to be no effect on growth beyond one year of life. Use of multicomponent fortifiers does not appear to be associated with adverse effects, although the total number of infants studied and the large amount of missing data reduces confidence in this conclusion. Blood urea levels are increased and blood pH levels minimally decreased, but the clinical significance of this is uncertain.
REVIEWER'S CONCLUSIONS: Multicomponent fortification of human milk is associated with short-term improvements in weight gain, linear and head growth. Despite the absence of evidence of long-term benefit and insufficient evidence to be reassured that there are no deleterious effects, it is unlikely that further studies evaluating fortification of human milk versus no supplementation will be performed. Further research should be directed toward comparisons between different proprietary preparations and evaluating both short-term and long-term outcomes in search of the "optimal" composition of fortifiers.
对于足月儿,母乳可提供充足营养以促进生长,还可能对免疫及母婴情感状态产生有益影响。然而,母乳在早产儿中的作用尚不太明确,因为其某些营养素含量不足以满足婴儿的估计需求。观察性研究表明,喂配方奶的婴儿比母乳喂养的婴儿生长速度更快。不过,母乳具有潜在的短期和长期益处。商业生产的多成分强化剂可提供额外营养素以补充母乳(形式为蛋白质、钙、磷、碳水化合物以及维生素和微量矿物质)。
主要目的是确定在母乳中添加多成分营养补充剂是否能使早产儿生长改善、骨代谢及神经发育结局改善且无显著不良反应。
检索了Cochrane对照试验中央注册库(CENTRAL,Cochrane图书馆,2003年第2期)、MEDLINE(检索时间为2003年8月29日),还检索了既往综述,包括交叉参考文献、摘要、会议及专题讨论会论文集、专家提供的信息,主要以英文进行期刊手工检索。
所有在新生儿病房环境中采用随机或半随机分配方式对早产儿母乳进行多种营养素补充或不补充的试验均符合要求。
采用Cochrane协作网及其新生儿综述组的标准方法提取数据,每位作者分别评估试验质量和提取数据,并使用相对危险度和加权均数差值进行数据合成。
用多成分强化剂补充母乳与短期内体重增加、身长和头围生长增加有关。对血清碱性磷酸酶水平无影响;对骨矿物质含量是否有影响尚不清楚。氮潴留和血尿素水平似乎升高。虽然一岁以后的生长似乎未受影响,但评估长期神经发育和生长结局的数据不足。使用多成分强化剂似乎与不良反应无关,不过所研究婴儿的总数及大量缺失数据降低了对这一结论的可信度。血尿素水平升高,血pH值略有下降,但其临床意义尚不确定。
母乳多成分强化与短期内体重增加、身长和头围生长改善有关。尽管缺乏长期益处的证据,且没有足够证据确保无有害影响,但评估母乳强化与不补充的进一步研究不太可能进行。进一步研究应针对不同专利制剂之间的比较,并评估短期和长期结局,以寻找强化剂的“最佳”成分。